Authors: SCHULMAN K BURKE J DRUMMOND M DAVIES L CARLSSON P GRUGER J HARRIS A LUCIONI C GISBERT R LLANA T TOM E BLOOM B WILLKE R GLICK H

Citation: K. Schulman et al., RESOURCE COSTING FOR MULTINATIONAL NEUROLOGIC CLINICAL-TRIALS - METHODS AND RESULTS, Health economics, 7(7), 1998, pp. 629-638

Authors: GLICK H WILLKE R POLSKY D LLANA T ALVES WM KASSELL N SCHULMAN K

Citation: H. Glick et al., ECONOMIC-ANALYSIS OF TIRILAZAD MESYLATE FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE - ECONOMIC-EVALUATION OF A PHASE-III CLINICAL-TRIAL IN EUROPE AND AUSTRALIA, International journal of technology assessment in health care, 14(1), 1998, pp. 145-160

Authors: SCHULMAN KA LLANA T YABROFF KR

Citation: Ka. Schulman et al., ECONOMIC-ASSESSMENT WITHIN THE CLINICAL DEVELOPMENT PROGRAM, Medical care, 34(12), 1996, pp. 89-95